Figure 1.
Potential therapeutics for obese, adult asthmatics described in this review modulate pathways common to several metabolic and nutritional disorders. This allows for the treatment of several comorbidities by targeting their common dysfunction as opposed to individual symptoms. Direct targets include AMPK, which regulates numerous cellular metabolic pathways involved in energy storage and NOS3, which modulates vascular and bronchial smooth muscle tone.